Jinhua municipal central hospital
Jinhua, Zhejiang, 321000, China
NCT Number: NCT02099279
Chronic obstructive lung disease (COPD) is a major cause of morbidity and mortality, and is a major reason for ICU admission. Cardiac function is often impaired in this disease but its association with clinical outcome has not been fully established. The study aims to investigate the association between cardiac dysfunction and clinclial outcomes.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Jinhua, Zhejiang, 321000, China
This is a prospective observational study conducted in a 47-bed mixed ICU of tertiary academic teaching hospital. The study will be performed between January 2014 to December 2015. All patients meeting the diagnostic criteria of AECOPD and admitted to ICU are potentially eligible for the present study. Relevant demographics and laboratory measurements are obtained. Transthoracic echocardiography (TTE) is performed immediately after ICU admission by experienced intensivists. Cox proportional hazard regression model is fitted by using stepwise forward selection and backward elimination technique. If linear assumption is not satisfied, the linear spline function will be used.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients underwent echocardiography examination
Time frame: 28 days after ICU admission
28 days after ICU admission; if a patient leave ICU before 28-days, it is considered as censored.
Time frame: from ICU admission to extubation, an expected average of 8 days
Jinhua Central Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03851991
COPD Patients
Shenyang, Liaoning, China
View Trial DetailsNCT06128902
COPD Patients
Ordu, Turkey (Türkiye)
View Trial DetailsNCT04869033
COPD Patients, Chronic Disease
Bangkok, Thailand
View Trial DetailsNCT02157935
COPD Patients, Chronic Disease
Andalusia, Alabama, United States
View Trial Details